CDC's HIV, Viral Hepatitis, STD, and Tuberculosis Prevention Budget

Funding overview

CDC funding and training support field staff, including Disease Intervention Specialists (DIS). DIS are frontline public health staff who help identify individuals who may not know they were exposed to STIs, HIV, and tuberculosis. These specially trained staff then connect patients to testing and treatment. DIS are also a critical piece of the public health infrastructure when emergencies and public health threats emerge, protecting Americans from a wide variety of outbreaks and epidemics, including HIV, tuberculosis, Ebola, influenza, Zika, and COVID-19.

CDC also provides financial assistance and assigns federal employees with on-the-ground experience to state, tribal, local and territorial health departments to reduce HIV, viral hepatitis, STI, and tuberculosis infections, link those who test positive to care and treatment, and prevent death. Upon request from state, tribal, local, and territorial health departments, CDC can provide direct assistance, which may include deploying CDC public health advisors or epidemiologists to assist with disease investigations. Through the American Rescue Plan Act of 2021, NCHHSTP will provide over $1,000,000,000 in funding to support DIS workforce over five years. For more information on the American Rescue Plan funding for DIS workforce please visit: CDC COVID-19 State, Tribal, Local, and Territorial Funding.

How is CDC funding used for HIV, viral hepatitis, STIs, tuberculosis prevention?

In FY 2022, the U.S. Congress enacted a spending bill that appropriated $1,345,056,000 to CDC to prevent and control HIV, viral hepatitis, STIs, tuberculosis, infectious diseases and the opioid epidemic, and to promote adolescent and school health. The FY 2022 operating budget1 amount was $1,242,862,946:

• Approximately 75% of the operating budget was awarded through extramural mechanisms. The majority of this funding is awarded to state, tribal, local, and territorial health departments, community-based organizations, national organizations, academic institutions, and education agencies as grants and cooperative agreements.
• Approximately 25% of the operating budget was spent on internal CDC resources that enable the nation's response to infectious disease, including world-class laboratories, outbreak response, cutting-edge research, and technical assistance to health departments and community-based organizations.

These expenditures achieved measurable reduction in risk factors, illness, and death in communities at all levels of social status.

Priorities

CDC uses a comprehensive approach to stop the spread of infectious diseases among people who use drugs. The nation’s public health crisis involving drug use of opioids and other drugs, including methamphetamines and cocaine, is fueling increases in infectious diseases, such as viral hepatitis and HIV.

HIV, viral hepatitis, STI, and tuberculosis laboratory services at CDC work around the clock to protect the health of all Americans. These laboratories use vital discoveries and cutting-edge technology, some of which are only available at CDC laboratories.

Funding over time

• FY2018 - FY2022 funding reflects enacted amounts.
• FY 2018 and FY 2019 enacted amounts are adjusted to reflect $7.222 million realignment from tuberculosis in the HIV, Viral Hepatitis, STI and Tuberculosis Prevention account to Global Tuberculosis in the Global Health account.
• FY 2019 - FY 2022 enacted amounts include funding for Infectious Diseases and the Opioid Epidemic.
• Enacted: The amount in the spending bill passed by both chambers of Congress and made into law.